Mesalamine Tablet, Delayed Release
Product Images NDC 31722-043

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 31722-043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Mesalaminedrtablets120tablets (Mesalaminedrtablets120tablets)

Mesalaminedrtablets120tablets (Mesalaminedrtablets120tablets)
Label for Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, oral dosage form by Camber Pharmaceuticals, Inc. The label indicates 120 tablets in the package and states once-daily use. It includes storage instructions, pharmacist dispensing guidelines, a barcode, manufacturer details, and a U.S. contact number.*
FDA Label Image

Mesalaminedrtabsstructure (Mesalaminedrtabsstructure)

Mesalaminedrtabsstructure (Mesalaminedrtabsstructure)
Chemical structure of mesalamine showing a benzene ring with amino, hydroxyl, and carboxylic acid functional groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.